Medartis Holding AG (MED) - Total Liabilities

Latest as of December 2025: CHF284.05 Million CHF ≈ $359.12 Million USD

Based on the latest financial reports, Medartis Holding AG (MED) has total liabilities worth CHF284.05 Million CHF (≈ $359.12 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore MED long-term asset investment ratio to see how much of total assets are deployed in long-term investments.

Medartis Holding AG - Total Liabilities Trend (2014–2025)

This chart illustrates how Medartis Holding AG's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Medartis Holding AG (MED) total assets.

Medartis Holding AG Competitors by Total Liabilities

The table below lists competitors of Medartis Holding AG ranked by their total liabilities.

Company Country Total Liabilities
Boai NKY Pharmaceuticals Ltd
SHE:300109
China CN¥658.24 Million
Cangzhou Mingzhu Plastic Co Ltd
SHE:002108
China CN¥3.33 Billion
AS LHV GROUP EO -10
F:ASU0
Germany €8.89 Billion
Cansino Biologics Inc
SHG:688185
China CN¥-4.93 Billion
Jiangsu Zongyi Co Ltd
SHG:600770
China CN¥1.25 Billion
Changsha DIALINE New Material Sci & Tech Co Ltd
SHE:300700
China CN¥848.12 Million
Sinar Mas Agro Resources and Technology Tbk PT
JK:SMAR
Indonesia Rp24.52 Trillion

Liability Composition Analysis (2014–2025)

This chart breaks down Medartis Holding AG's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See MED net asset quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.21 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 1.03 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.51 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Medartis Holding AG's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Medartis Holding AG (2014–2025)

The table below shows the annual total liabilities of Medartis Holding AG from 2014 to 2025.

Year Total Liabilities Change
2025-12-31 CHF284.05 Million
≈ $359.12 Million
+49.25%
2024-12-31 CHF190.31 Million
≈ $240.61 Million
+101.23%
2023-12-31 CHF94.58 Million
≈ $119.57 Million
+4.95%
2022-12-31 CHF90.11 Million
≈ $113.93 Million
+21.47%
2021-12-31 CHF74.18 Million
≈ $93.79 Million
+6.35%
2020-12-31 CHF69.76 Million
≈ $88.19 Million
-4.36%
2019-12-31 CHF72.94 Million
≈ $92.21 Million
+94.13%
2018-12-31 CHF37.57 Million
≈ $47.50 Million
-66.88%
2017-12-31 CHF113.45 Million
≈ $143.44 Million
+15.60%
2016-12-31 CHF98.14 Million
≈ $124.08 Million
-34.56%
2015-12-31 CHF149.97 Million
≈ $189.61 Million
-1.51%
2014-12-31 CHF152.28 Million
≈ $192.52 Million
--

About Medartis Holding AG

SW:MED Switzerland Medical Devices
Market Cap
$1.30 Billion
CHF1.02 Billion CHF
Market Cap Rank
#8628 Global
#117 in Switzerland
Share Price
CHF82.30
Change (1 day)
-1.91%
52-Week Range
CHF72.00 - CHF97.50
All Time High
CHF145.60
About

Medartis Holding AG, a medical device company, engages in the development, manufacturing, and sales of implant solutions worldwide. The company's medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. It provides products for the hand, wrist, forearm, elbow, shoulder, and foot and ankle, a… Read more